Parkinson s disease is a progressive disorder that is caused by the degeneration of nerve cells in the part of the brain called the substantia nigra, which.
/PRNewswire/ DelveInsight s Multiple System Atrophy Market Insights report includes a comprehensive understanding of current treatment practices, multiple.
AskBio Adds CNS Gene Therapy Programs in Parkinson’s Disease and Multiple System Atrophy Clinical team led by neurological gene therapy expert, Dr. Krystof Bankiewicz, joins AskBio
January 28, 2021 09:20 ET | Source: Asklepios BioPharmaceutical, Inc. Asklepios BioPharmaceutical, Inc. Research Triangle Park, North Carolina, UNITED STATES
RESEARCH TRIANGLE PARK, N.C., Jan. 28, 2021 (GLOBE NEWSWIRE) Asklepios BioPharmaceutical, Inc. (AskBio), a clinical-stage adeno-associated virus (AAV) gene therapy company and wholly owned subsidiary of Bayer AG, today announced that the clinical team from Brain Neurotherapy Bio, Inc., a gene therapy company based in Columbus, Ohio, has joined AskBio to expand its clinical pipeline for the treatment of neurodegenerative disorders. Brain Neurotherapy Bio (BNB) was established in 2018 by Krystof Bankiewicz, MD, PhD, in association with AskBio founders Sheila Mikhail, JD, and Jude